Bahamdain FO. Retracted: Effect of dolutegravir on plasma glucose among human immunodeficiency virus patients in a community health center setting. Int J Community Med Public Health [Internet]. 2022 Feb. 28 [cited 2025 Oct. 27];9(3):1178-82. Available from: https://www.ijcmph.com/index.php/ijcmph/article/view/9571